Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation

NCT02535286

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • TG Therapeutics Investigational Trial Site New York, United States
  • TG Therapeutics Investigational Trial Site Durham, North Carolina, United States
  • TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States
  • TG Therapeutics Investigational Trial Site Seattle, Washington, United States
View Trial Details
Completed

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Completed

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

NCT02582879

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Northwest Alabama Cancer Center, PC Muscle Shoals, Alabama, United States
  • Arizona Oncology Associates, PC - HAL Glendale, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
View all 192 locations
View Trial Details
Completed

A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities

NCT02915224

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University General Hospital of Alexandroupolis; Haemotology Alexandroup, Greece
  • Laiko General Hospital of Athens; A Propedeutical Clinic of Internal Medicine Athens, Greece
  • Laiko General Hospital; Hematology Clinic Athens, Greece
  • General Hospital G. Gennimatas; Hematology Dept. Athens, Greece
View Trial Details

Related conditions